These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 28176640)

  • 1. Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses.
    Kamal MA; Shakil S; Nawaz MS; Yu QS; Tweedie D; Tan Y; Qu X; Greig NH
    CNS Neurol Disord Drug Targets; 2017; 16(7):820-827. PubMed ID: 28176640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of human serum butyrylcholinesterase inhibition by a novel experimental Alzheimer therapeutic, dihydrobenzodioxepine cymserine.
    Kamal MA; Klein P; Luo W; Li Y; Holloway HW; Tweedie D; Greig NH
    Neurochem Res; 2008 May; 33(5):745-53. PubMed ID: 17985237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis of the inhibition of human butyrylcholinesterase with cymserine.
    Kamal MA; Al-Jafari AA; Yu QS; Greig NH
    Biochim Biophys Acta; 2006 Feb; 1760(2):200-6. PubMed ID: 16309845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrahydrofurobenzofuran cymserine, a potent butyrylcholinesterase inhibitor and experimental Alzheimer drug candidate, enzyme kinetic analysis.
    Kamal MA; Qu X; Yu QS; Tweedie D; Holloway HW; Li Y; Tan Y; Greig NH
    J Neural Transm (Vienna); 2008 Jun; 115(6):889-98. PubMed ID: 18235987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of human serum butyrylcholinesterase and its inhibition by a novel experimental Alzheimer therapeutic, bisnorcymserine.
    Kamal MA; Klein P; Yu QS; Tweedie D; Li Y; Holloway HW; Greig NH
    J Alzheimers Dis; 2006 Sep; 10(1):43-51. PubMed ID: 16988481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular interaction study of N1-p-fluorobenzyl-cymserine with TNF-α , p38 kinase and JNK kinase.
    Batool S; Nawaz MS; Greig NH; Rehan M; Kamal MA
    Antiinflamm Antiallergy Agents Med Chem; 2013; 12(2):129-35. PubMed ID: 23360257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
    Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
    Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease.
    Yu YF; Huang YD; Zhang C; Wu XN; Zhou Q; Wu D; Wu Y; Luo HB
    ACS Chem Neurosci; 2017 Nov; 8(11):2522-2534. PubMed ID: 28783948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New cholinesterase inhibitors for Alzheimer's disease: Structure activity relationship, kinetics and molecular docking studies of 1-butanoyl-3-arylthiourea derivatives.
    Larik FA; Shah MS; Saeed A; Shah HS; Channar PA; Bolte M; Iqbal J
    Int J Biol Macromol; 2018 Sep; 116():144-150. PubMed ID: 29729344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
    Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico modeling for dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes in Alzheimer's disease.
    Kumar V; Saha A; Roy K
    Comput Biol Chem; 2020 Oct; 88():107355. PubMed ID: 32801088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease.
    Chufarova N; Czarnecka K; Skibiński R; Cuchra M; Majsterek I; Szymański P
    Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800050. PubMed ID: 29870588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease.
    Li Q; Yang H; Chen Y; Sun H
    Eur J Med Chem; 2017 May; 132():294-309. PubMed ID: 28371641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase.
    Greig NH; Utsuki T; Yu Q; Zhu X; Holloway HW; Perry T; Lee B; Ingram DK; Lahiri DK
    Curr Med Res Opin; 2001; 17(3):159-65. PubMed ID: 11900310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human cholinesterases by drugs used to treat Alzheimer disease.
    Darvesh S; Walsh R; Kumar R; Caines A; Roberts S; Magee D; Rockwood K; Martin E
    Alzheimer Dis Assoc Disord; 2003; 17(2):117-26. PubMed ID: 12794390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lepidine B from Lepidium sativum Seeds as Multi-Functional Anti- Alzheimer's Disease Agent: In Vitro and In Silico Studies.
    Talia S; Benarous K; Lamrani M; Yousfi M
    Curr Comput Aided Drug Des; 2021; 17(3):360-377. PubMed ID: 32116197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aaptamine - a dual acetyl - and butyrylcholinesterase inhibitor as potential anti-Alzheimer's disease agent.
    Miao S; He Q; Li C; Wu Y; Liu M; Chen Y; Qi S; Gong K
    Pharm Biol; 2022 Dec; 60(1):1502-1510. PubMed ID: 35968601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one scaffold derivatives: Synthesis and biological evaluation as selective BuChE inhibitors.
    Chen SC; Qiu GL; Li B; Shi JB; Liu XH; Tang WJ
    Eur J Med Chem; 2018 Mar; 147():194-204. PubMed ID: 29438888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship studies of benzyl-, phenethyl-, and pyridyl-substituted tetrahydroacridin-9-amines as multitargeting agents to treat Alzheimer's disease.
    Osman W; Mohamed T; Sit VM; Vasefi MS; Beazely MA; Rao PP
    Chem Biol Drug Des; 2016 Nov; 88(5):710-723. PubMed ID: 27282589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses.
    Kuhl DE; Koeppe RA; Snyder SE; Minoshima S; Frey KA; Kilbourn MR
    Ann Neurol; 2006 Jan; 59(1):13-20. PubMed ID: 16278840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.